Print

Aerial BioPharma Receives FDA Orphan Drug Designation for Narcolepsy Drug in Development  
8/29/2012 9:41:36 AM

MORRISVILLE, N.C.--(BUSINESS WIRE)--Aerial BioPharma, a biopharmaceutical company focused on developing biologics and small molecules for conditions in the central nervous system, has received orphan drug designation for its narcolepsy drug in development.
//-->